Cargando…

SAT-308 Obsessive and Compulsive Behavioral Change during Combination Treatment of Aromatase Inhibitor and Recombinant Human Growth Hormone in Early Puberty Patient: A Case Report

Aromatase inhibitor (AI), mostly combined with recombinant human growth hormone (rhGH), has been proposed as a effective treatment to improve the final adult height in short pubertal boys by delaying growth plate closure. However, safety concerns also remain, because of limited safety profile of AI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Ju-hee, Kim, Dae Hyun, Suh, Chae-ri, Kim, So Yeon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Pediatric Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552207/ http://dx.doi.org/10.1210/js.2019-SAT-308

Ejemplares similares

SAT-305 Hyperactive Behavioral Change during Combination Treatment of Aromatase Inhibitor and Recombinant Human Growth Hormone in Early Puberty Patient: A Case Report
por: Choi, Ju-hee, et al.
Publicado: (2019)

SAT-303 Combined Treatment of Gonadotropin Releasing Hormone Agonist and Recombinant Human Growth Hormone in Cental Precocious Puberty Patient with Underlying Leri Weill Dyschondrosteosis
por: Choi, Ju-hee, et al.
Publicado: (2019)

SAT-304 Unexplained Asymptomatic Hyperestrogenism in Central Precocious Puberty Patient Treated with Gonadotropin Releasing Hormone Agonist
por: Kim, Dae Hyun, et al.
Publicado: (2019)

SAT-307 Sudden Unexpected Vaginal Bleeding Caused by Temporal Reactivation of Hypothalamic-Hypophyseal-Gonadal Axis during Gonadotropin Releasing Hormone Agonist Treatment for Central Precocious Puberty
por: Kim, Dae Hyun, et al.
Publicado: (2019)

SAT-292 Superimposed Peripheral Precocious Puberty Caused by Autonomous Ovarian Follicular Cyst in Being Treated Central Precocious Puberty Patient: Underlying Condition of Herlyn-Werner-Wunderlich Syndrome
por: Kim, Dae Hyun, et al.
Publicado: (2019)

SAT-101 The Booster Effect of Aromatase Inhibitor to Overcome Waning Effect of Recombinant Human Growth Hormone
por: Kim, Dae Hyun, et al.
Publicado: (2020)

SAT-102 Height Improvement with Recombinant Human Growth Hormone Therapy at Terminal Stage of Growth
por: Kim, Dae Hyun, et al.
Publicado: (2020)

SAT-296 Congenital Adrenal Hyperplasia Presenting as Central Precocious Puberty
por: Malineni, Vikas, et al.
Publicado: (2019)

SAT-073 Testicular Abnormalities in the Absence of Precocious Puberty in Mccune-Albright Syndrome
por: Verma, Arushi, et al.
Publicado: (2020)

SUN-086 Pilot Study Using Aromatase Inhibitor in Puberty of Boys With Partial Androgen Insensitivity: Report of Three Cases
por: Maciel-Guerra, Andrea Trevas, et al.
Publicado: (2020)

SAT-LB047 Circulating IGF-1, MKRN3, and Kisspeptin in Girls during the Onset of Puberty
por: Yang, Fan
Publicado: (2019)

SAT-278 Changes in Biochemical and Electrocardiographic Findings During Insulin Tolerance Test
por: Choi, Han Saem, et al.
Publicado: (2019)

SAT-286 A Previously Undescribed Combination of Aromatase Deficiency and Non-Classical Congenital Adrenal Hyperplasia in an Hispanic Teenage Male
por: Gottesman, Bethany, et al.
Publicado: (2019)

SAT-290 Expanded Phenotype Associated with RNF135 Intragenic Deletion in a Girl with Peripheral Precocious Puberty
por: Danowitz, Melinda, et al.
Publicado: (2019)

Long-Term Effect of Aromatase Inhibition in Aromatase Excess Syndrome
por: Binder, Gerhard, et al.
Publicado: (2021)

MON-243 The Difference of Body Mass Index Score before and after Gonadotropin-Releasing Hormone Agonist Treatment in Cerntral Precocious Puberty Girls
por: Choi, Yujung, et al.
Publicado: (2019)

ODP386 Growth Velocity and Growth Hormone Deficiency During Puberty
por: Currais, Carolina, et al.
Publicado: (2022)

SAT-106 Growth Hormone Treatment Response in Children
por: Rath, Mitchell, et al.
Publicado: (2020)

OR18-2 Clinical, Hormonal and Genetic Characterization of Familial Central Precocious Puberty
por: Argente, Jesús, et al.
Publicado: (2022)

LBODP081 The Relationship Between Body Mass Index Changes And Bone Age Progression During Gonadotropin-releasing Hormone Agonist Treatment In Girls With Idiopathic Central Precocious Puberty
por: Kim, Seulki, et al.
Publicado: (2022)

MON-061 A Case of Central Precocious Puberty Patient with Arnold Chiari Malformation, Type I
por: Kim, Dae Hyun, et al.
Publicado: (2020)

SAT-108 Growth Hormone Deficiency in a Patient with Ectodermal Dysplasia
por: Alkhaled, Lina, et al.
Publicado: (2020)

SAT-288 Successful Virilization of a PAIS Patient with a Missense Mutation In The Ligand-binding Domain Of The Androgen Receptor with Combined High-dose Testosterone and Aromatase Inhibitor
por: MORAES, DANIELA, et al.
Publicado: (2019)

The Obsessive–Compulsive Symptoms in Tic Disorders and the Psychometric Properties of Children’s Yale–Brown Obsessive–Compulsive Scale: An Evidence-Based Survey in a Chinese Sample
por: Yan, Junjuan, et al.
Publicado: (2022)

SAT-247 Two-Year Treatment with Metformin during Puberty Is Associated with Improvements in Body Composition, but Not in Insulin Sensitivity or β-Cell Function in Obese Youth
por: Kelsey, Megan, et al.
Publicado: (2019)

SAT348 Changes In BMI Z-score After Presentation For Early Breast Budding Is Associated With Rapidly Progressive Puberty And Treatment With GnRH Analogues
por: Jung, Hae Woon, et al.
Publicado: (2023)

MON-241 Relationship between Final Height and Birth Weight after Gonadotropin-Releasing Hormone Agonist Treatment in Girls with Central Precocious Puberty
por: Kim, Eun Young, et al.
Publicado: (2019)

SAT-070 Nutritional Deficiency of Calcium Mimicking P Seudohypoparathyroidism
por: Lee, Yoonji, et al.
Publicado: (2020)

SAT-090 Factors Affecting IGF-1 Level and Correlation with Growth Response During Growth Hormone Treatment in LGS Patients
por: Kim, Jihyun, et al.
Publicado: (2020)

SAT-284 Sex Hormone Replacement Therapy in Turner Syndrome and the Impact on Morbidity and Mortality
por: Viuff, Mette, et al.
Publicado: (2019)

MON-063 Rare Cases of Local and Systemic Allergic Reactions Associated with Recombinant Human Growth Hormone Treatment Including Fixed Drug Eruption and Anaphylaxis
por: Kim, Dae Hyun, et al.
Publicado: (2020)

THU194 Growth Pattern And Related Predictors Of Gonadotropin-releasing Hormone Analog Treatment In Girls With Precocious Puberty
por: Ouyang, Lixue, et al.
Publicado: (2023)

SAT-088 The Incidence of Neurological Symptoms During Growth Hormone Therapy in Patients with Chiari Malformation
por: Alexandrov, Alice, et al.
Publicado: (2020)

SAT-107 Improved Adult Height in Brazilian Turner Syndrome Patients Treated with Growth Hormone
por: Scalco, Renata Da Cunha, et al.
Publicado: (2020)

SUN-259 Recombinant Growth Hormone Therapy for Children with Turner Syndrome in Korea: A Phase III Randomized Trial
por: Kim, Jinsup, et al.
Publicado: (2019)

Gonadotropin-releasing hormone analogue and recombinant human growth hormone treatment for idiopathic central precocious puberty in girls
por: Shi, Yuzhen, et al.
Publicado: (2022)

SAT-105 The Natural History of Pituitary Cysts in Patients with Growth Hormone Deficiency and Idiopathic Short Stature
por: El-Naghy, Zeyad, et al.
Publicado: (2020)

THU167 Trends Of Recombinant Human Growth Hormone Treatment In Korea: Data From The Health Insurance Review And Assessment Service 2015-2020
por: Kim, Jaehyun, et al.
Publicado: (2023)

Genomics of Obsessive-Compulsive Disorder—Toward Personalized Medicine in the Era of Big Data
por: Szejko, Natalia, et al.
Publicado: (2021)

6-Month Subcutaneous Leuprolide Acetate Effectively Suppresses Clinical Signs of Puberty in Children With Central Precocious Puberty
por: Eugster, Erica A, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vir2hm6je9ui6l2anfqmd8dp05